| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-05 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |